We are live on ! Find out more
PJP icon

Invesco Pharmaceuticals ETF
PJP

119 hedge funds and large institutions have $151M invested in Invesco Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

118% more capital invested

Capital invested by funds: $69.2M → $151M (+$81.8M)

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

15.89% more ownership

Funds ownership: 21.99% → 37.88% (+16%)

13% more funds holding

Funds holding: 105 → 119 (+14)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $259K

Holders
119
Holders Change
+14
Holders Change %
+13.33%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
33
Reduced
21
Closed
11
Calls
–
Puts
$259K
Net Calls
-$259K
Net Calls Change
-$259K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$24.4M
2
HighTower Advisors
HighTower Advisors
Illinois
+$23.4M
3
Bank of America
Bank of America
North Carolina
+$5.51M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$5.45M
5
CI
Cavalier Investments
Georgia
+$4.85M

Top Sellers

Rank Fund Capital Flow
1
WI
WBI Investments
New Jersey
-$739K
2
IDA
Intelligence Driven Advisers
California
-$565K
3
HAS
HBW Advisory Services
California
-$533K
4
GC
Grimes & Company
Massachusetts
-$502K
5
BlackRock
BlackRock
New York
-$367K
Name Holding Trade Value Shares
Change 		Change in
Stake
FGA
101
Fortis Group Advisors
New Jersey
$10.4K – – –
SWA
102
Strategic Wealth Advisors
Arizona
$8K – – –
CA
103
Clearstead Advisors
Ohio
$6.35K +$6.44K +61 New
AAG
104
Armstrong Advisory Group
Massachusetts
$6.23K – – –
BTC
105
Bank & Trust Company
Illinois
$6.23K – – –
William Blair & Company
106
William Blair & Company
Illinois
$6.23K – – –
ATS
107
Ashton Thomas Securities
New York
$5.71K – – –
Qube Research & Technologies (QRT)
108
Qube Research & Technologies (QRT)
United Kingdom
$5.4K -$317 -3 -5%
SWM
109
Spire Wealth Management
Virginia
$5.4K – – –
UBS AM
110
UBS AM
Illinois
$5.19K – – –
HNB
111
Huntington National Bank
Ohio
$4.05K – – –
FFO
112
Fortitude Family Office
Arizona
$3.21K +$3.27K +31 New
Russell Investments Group
113
Russell Investments Group
United Kingdom
$2.59K +$2.64K +25 New
National Bank of Canada
114
National Bank of Canada
Quebec, Canada
$2.49K – – –
WT
115
Whittier Trust
California
$1.95K – – –
AUB
116
Atlantic Union Bankshares
Virginia
$1.81K – – –
ADL
117
Asset Dedication LLC
California
$1.35K – – –
EWA
118
EverSource Wealth Advisors
Alabama
$311 – – –
QAM
119
Q3 Asset Management
Michigan
$284 +$290K +2,741 New
WP
120
WealthShield Partners
North Carolina
$208 +$211 +2 New
WI
121
WBI Investments
New Jersey
– -$739K -7,068 Closed
IDA
122
Intelligence Driven Advisers
California
– -$565K -5,400 Closed
HAS
123
HBW Advisory Services
California
– -$533K -5,097 Closed
GC
124
Grimes & Company
Massachusetts
– -$502K -4,804 Closed
KAS
125
Kestra Advisory Services
Texas
– -$192K -1,833 Closed
2 3 4
5
6

PJP Hedge Fund Activity: Q1 2026 in Review

119 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2026, worth a combined $151M — up 118% from $69.2M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new PJP positions and 11 closed out — a net gain of 17 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $24.4M. The largest seller was WBI Investments, exiting entirely with an estimated $739K sold.

  • 119 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2026, up from 105 in Q4 2025.
  • Funds reported $151M of Invesco Pharmaceuticals ETF stock for Q1 2026, up 118% quarter-over-quarter.
  • 28 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2026 and 11 closed out, a net change of +17 holders.
  • The largest Invesco Pharmaceuticals ETF buyer in Q1 2026 was Morgan Stanley, an estimated $24.4M added.
  • The largest Invesco Pharmaceuticals ETF seller in Q1 2026 was WBI Investments, an estimated $739K sold.

Based on aggregated 13F filings for Q1 2026.